With the latest 10 Q the risk/reward ratio got smashed again as they raised issues with their funds again and possibility of BK despite the latest Takeda agreement. I had to read their latest 10 Q over and over in order to realize that this management (CEO, CFO, etc) are not the only incompetent folks there but also their board, who supposed to watch over things, does not seem to have a clue about how to control the costs and while the company does not have much Omontys related expenses they seem to continue to be in real trouble.
With such incompetent and stupid people running this company to the ground who says that one morning they may not opt for BK? They pulled the plug on a billion dollar drug over 0.02% fatality rate didn't they?
With such major risks to me any entry point without a bounce off the 0.80 low of earlier this week is pure gamble and a not so smart one. It has to test 0.80 before I would consider getting back in.